Hoth Therapeutics Stock Forecast - Naive Prediction
| HOTH Stock | USD 1.05 0.02 1.87% |
The Naive Prediction forecasted value of Hoth Therapeutics on the next trading day is expected to be 1.10 with a mean absolute deviation of 0.04 and the sum of the absolute errors of 2.21. Hoth Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Hoth Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 23rd of January 2026 the relative strength index (rsi) of Hoth Therapeutics' share price is below 20 . This usually indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.08) | EPS Estimate Current Year (0.81) | EPS Estimate Next Year (0.43) | Wall Street Target Price 5 | EPS Estimate Current Quarter (0.07) |
Using Hoth Therapeutics hype-based prediction, you can estimate the value of Hoth Therapeutics from the perspective of Hoth Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Hoth Therapeutics on the next trading day is expected to be 1.10 with a mean absolute deviation of 0.04 and the sum of the absolute errors of 2.21. Hoth Therapeutics after-hype prediction price | USD 1.06 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Hoth Therapeutics to cross-verify your projections. Hoth Therapeutics Additional Predictive Modules
Most predictive techniques to examine Hoth price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Hoth using various technical indicators. When you analyze Hoth charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Hoth Therapeutics Cash Forecast
Predicting cash flow or other financial metrics requires analysts to utilize a variety of statistical methods, techniques, and algorithms. These tools help uncover hidden patterns in the Hoth Therapeutics' financial statements, enabling forecasts of their impact on future stock prices.
Cash | First Reported 2017-12-31 | Previous Quarter 9 M | Current Value 7.8 M | Quarterly Volatility 4.8 M |
Hoth Therapeutics Naive Prediction Price Forecast For the 24th of January
Given 90 days horizon, the Naive Prediction forecasted value of Hoth Therapeutics on the next trading day is expected to be 1.10 with a mean absolute deviation of 0.04, mean absolute percentage error of 0, and the sum of the absolute errors of 2.21.Please note that although there have been many attempts to predict Hoth Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Hoth Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Hoth Therapeutics Stock Forecast Pattern
| Backtest Hoth Therapeutics | Hoth Therapeutics Price Prediction | Buy or Sell Advice |
Hoth Therapeutics Forecasted Value
In the context of forecasting Hoth Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Hoth Therapeutics' downside and upside margins for the forecasting period are 0.01 and 4.45, respectively. We have considered Hoth Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Hoth Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Hoth Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.9211 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0362 |
| MAPE | Mean absolute percentage error | 0.0317 |
| SAE | Sum of the absolute errors | 2.2106 |
Predictive Modules for Hoth Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Hoth Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Hoth Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hoth Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Hoth Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Hoth Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Hoth Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Hoth Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Hoth Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Hoth Therapeutics' historical news coverage. Hoth Therapeutics' after-hype downside and upside margins for the prediction period are 0.05 and 4.44, respectively. We have considered Hoth Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Hoth Therapeutics is very risky at this time. Analysis and calculation of next after-hype price of Hoth Therapeutics is based on 3 months time horizon.
Hoth Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Hoth Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Hoth Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Hoth Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.40 | 3.35 | 0.01 | 0.10 | 7 Events / Month | 5 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.05 | 1.06 | 0.95 |
|
Hoth Therapeutics Hype Timeline
Hoth Therapeutics is currently traded for 1.05. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of -0.1. Hoth is anticipated to increase in value after the next headline, with the price projected to jump to 1.06 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 0.95%, whereas the daily expected return is currently at -0.4%. The volatility of related hype on Hoth Therapeutics is about 1303.5%, with the expected price after the next announcement by competition of 0.95. Net Loss for the year was (8.19 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next anticipated press release will be in about 7 days. Check out Historical Fundamental Analysis of Hoth Therapeutics to cross-verify your projections.Hoth Therapeutics Related Hype Analysis
Having access to credible news sources related to Hoth Therapeutics' direct competition is more important than ever and may enhance your ability to predict Hoth Therapeutics' future price movements. Getting to know how Hoth Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Hoth Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CRIS | Curis Inc | (0.04) | 8 per month | 0.00 | (0.14) | 9.60 | (8.13) | 33.70 | |
| BCTX | Briacell Therapeutics Corp | (1.00) | 9 per month | 0.00 | (0.07) | 13.96 | (9.09) | 98.43 | |
| PALI | Palisade Bio | 0.04 | 7 per month | 6.66 | 0.04 | 13.86 | (10.26) | 31.35 | |
| PCSA | Processa Pharmaceuticals | (0.70) | 8 per month | 0.00 | (0.01) | 11.68 | (14.08) | 164.28 | |
| ASBP | Aspire BioPharma | (0.40) | 10 per month | 0.00 | (0.21) | 19.52 | (23.85) | 63.79 | |
| LEXX | Lexaria Bioscience Corp | (0.09) | 9 per month | 8.87 | 0.02 | 9.23 | (9.68) | 46.84 | |
| FBLG | FibroBiologics Common Stock | (0.01) | 11 per month | 8.35 | 0.01 | 13.79 | (12.82) | 47.13 | |
| PULM | Pulmatrix | (0.12) | 9 per month | 0.00 | (0.13) | 6.62 | (5.75) | 51.95 | |
| DARE | Dare Bioscience | (0.08) | 8 per month | 3.77 | (0.02) | 6.55 | (6.98) | 26.52 | |
| ENTO | Entero Therapeutics | (0.17) | 10 per month | 7.81 | 0.07 | 16.50 | (17.06) | 56.75 |
Other Forecasting Options for Hoth Therapeutics
For every potential investor in Hoth, whether a beginner or expert, Hoth Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Hoth Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Hoth. Basic forecasting techniques help filter out the noise by identifying Hoth Therapeutics' price trends.Hoth Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Hoth Therapeutics stock to make a market-neutral strategy. Peer analysis of Hoth Therapeutics could also be used in its relative valuation, which is a method of valuing Hoth Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Hoth Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Hoth Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Hoth Therapeutics shares will generate the highest return on investment. By undertsting and applying Hoth Therapeutics stock market strength indicators, traders can identify Hoth Therapeutics entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 1.05 | |||
| Day Typical Price | 1.05 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.02) |
Hoth Therapeutics Risk Indicators
The analysis of Hoth Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Hoth Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting hoth stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.54 | |||
| Standard Deviation | 3.38 | |||
| Variance | 11.4 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Hoth Therapeutics
The number of cover stories for Hoth Therapeutics depends on current market conditions and Hoth Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Hoth Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Hoth Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Hoth Therapeutics Short Properties
Hoth Therapeutics' future price predictability will typically decrease when Hoth Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Hoth Therapeutics often depends not only on the future outlook of the potential Hoth Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Hoth Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6.4 M | |
| Cash And Short Term Investments | 7 M |
Check out Historical Fundamental Analysis of Hoth Therapeutics to cross-verify your projections. For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hoth Therapeutics. If investors know Hoth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hoth Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Hoth Therapeutics is measured differently than its book value, which is the value of Hoth that is recorded on the company's balance sheet. Investors also form their own opinion of Hoth Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Hoth Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hoth Therapeutics' market value can be influenced by many factors that don't directly affect Hoth Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hoth Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hoth Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hoth Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.